The Fish Oil market is expected to reach USD 10,401.5 million in 2025 and is projected to reach a total value of USD 24,624.1 million by 2035. This represents a compound annual growth rate (CAGR) of 9% during the forecast period from 2025 to 2035.
The fish oil market has a great potential to grow globally standing at the peak among six product segments and supported by the persistent demand in nutraceuticals, pharmaceuticals, aquaculture, and the functional foods sector. The drive is pushed mainly by the consumer awareness of the omega-3 fatty acids health benefits continuous rise of the manufacturers on product innovation, regulatory compliance and sustainability path they chose to secure more market share.
The quickly growing stakeholders in the fish oil business have realised that the most important demand drivers are the fish farming sector's increased operations, mental well-being, and cardiovascular diseases that can be helped by functional foods that are rich in omega-3. Companies are expanding their fish farming and aquaculture feed optimization operations together with the demand for refined fish oil concentrates to be used for these products.
The market is being reshaped by various factors, including the trend towards stronger omega-3 supplements, the rising pharmaceutical applications, and the shift in dietary habits. The surging numbers of elderly people, especially in Europe, North America, and Japan, are pushing the need for special omega-3s that are meant for the health of the heart and the brain.
Moreover, gym-goers, athletes, and today’s youth are embracing the incorporation of fish oil-based products into their daily diets, thus, boosting the demand for flexible softgels, emulsions, and chewable omega-3 supplements.
Aquaculture still covers the largest part of the fish oil industry, with farmers of salmon, shrimp, and trout being among the most frequent users of omega-3 feed additives to boost fish growth, immunity, and nutritional value. Although, you face some challenges like fishing quotas, climate changes, and sourcing restrictions that drive companies to seek alternative marine sources, and promote sustainable fisheries.
The major manufacturers such as DSM, BASF, Croda International, GC Rieber VivoMega, and Golden Omega are keen on product differentiation through high-purity, oxidation-resistant, and concentrated fish oil formulations.
The breakthroughs such as microencapsulation, molecular distillation, and ultra-processed extraction of fish oil are helping the enterprises in meeting the demanding regulatory standards in the pharmaceutical, infant formula, and medical food sectors. Some of the companies even move to DTC e-commerce and personalized supplement trends which are driving their sales growth.
In view of the future, the fish oil market will see even stronger regulatory controls, higher customer purity expectations, and new technological developments in product stabilization. The birth of the alternative omega-3 sources like algae oil and krill oil will bring competition but premium-grade fish oils will continue to be a high-value segment.
By pathing the way for the supply chain to become more efficient, manufacturers are covering the bases with sustainability certifications and by implementing advanced refining processes thus the fish oil market should thrive in the next decade.
Explore FMI!
Book a free demo
The below table presents a comparative assessment of the variation in CAGR over six months for the base year (2024) and current year (2025) for the global industry. This analysis reveals crucial shifts in market performance and indicates revenue realization patterns, thus providing stakeholders with a better vision of the growth trajectory over the year. The first half of the year, or H1, spans from January to June. The second half, H2, includes the months from July to December.
| Particular | Value CAGR |
|---|---|
| H1 2024 | 8.7% (2024 to 2034) |
| H2 2024 | 9.3% (2024 to 2034) |
| H1 2025 | 8.9% (2025 to 2035) |
| H2 2025 | 9.5% (2025 to 2035) |
The global industry's predicted compound annual growth rate (CAGR) over a semi-annual period from 2025 to 2035 is shown in the above table. The business is anticipated to grow at a CAGR of 8.7% in the first half (H1) of 2024 and then slightly faster at 9.3% in the second half (H2) of the same year.
The CAGR is anticipated to decrease somewhat to 8.9% in the first half of 2025 and continues to grow at 9.5% in the second half. The industry saw a decline of 35 basis points in the first half (H1 2025) and an increase of 46 basis points in the second half (H2 2025).
Pharmaceutical-Grade Omega-3 Dominance
The medical applications of high-concentration omega-3 fish oils are shifting the supply chains primarily turmeric fish oils, which is rising as a consequence. Prescription omega-3-based drugs such as Vascepa® and Lovaza® are commonly used for the treatment of cardiovascular diseases, high triglyceride levels, and inflammatory disorders.
To optimize the EPA and DHA content while adhering to the pharmaceutical industry's tough regulations, the companies are investing in ultra-purification processes. Transition to prescription-grade fish oil means higher profits and its R&D for new medical applications. Companies including DSM, BASF, and Croda are creating clinical-grade omega-3 formulations focused on improving the bioavailability and the delivery of drugs.
This phenomenon is persuading suppliers to narrow down product ranges according to purity, concentration levels (85%+), and absorption efficacy. The fish oil that was before a generic supplement is now a serious targeted medical intervention.
Volatility in Wild-Catch Fisheries and Raw Material Sourcing
Wild-caught fish, especially the Peruvian and Chilean anchovies, are the major source of fish oil for the global fish oil market. The uncertain supply of raw materials caused by climate change, the effects of El Niño, and restricted fishing quotas has led to price fluctuations and subsequent problems within the supply chain.
The manufacturers are increasingly opting for diversified sourcing, by moving to other fish species (e.g., sardines, mackerel) and seafood processing by-product extraction. Companies like TASA and Omega Protein are refining their extraction methods to get the best results as well as to research into krill oil and algal omega-3 as additional sources of supply.
A supply chain WWTP is now paramount, companies are joining hands on the fishery partnerships, and are also engaging cold storage logistics to keep levels stable. The sustainability-certified fish oil sources are also becoming more popular, and they ensure adherence to global fisheries laws.
Rising Demand from Aquaculture and Livestock Nutrition
The aquaculture industry is one of the main sanctions of fish oil, especially in the case of the salmon and shrimp farming industries, as there is a big demand for fish oil-rich EPA and DHA which increases growth and immune system health in fishes. With the growth of the global seafood market, fish farmers are starting to use more and more nutrient-rich feed formulations for the quality and productivity of fish.
This has caused an increase in competition on fish oil between the nutrition of humans and aquaculture sectors, which has led to the need for manufacturers to balance the supply. Innovative fish oil concentrates for feed applications are the area of focus for companies like Pelagia and GC Rieber VivoMega who provide exclusive ratios of EPA/DHA that are particular to each type of fish.
Furthermore, it has been noted that livestock nutrition uses omega-3 to improve the quality of milk and meat products, thus resulting in additional income. The central thought is to develop the high-stability fish oils that have longer shelf-life and hence less oxidation in the feed.
Regulatory Push for Heavy Metal and Contaminant-Free Products
Tighter rules and regulations on the heavy metals, dioxins, and PCBs are driving innovation and are changing the landscape of the fish oil market. Regulatory bodies such as the FDA, EFSA, and GOED have imposed stricter limits on the contaminants, which have consequently brought about the need for high-purity fish oil products.
As a move to deal with this, the manufacturers have turned to state-of-the-art technology such as molecular distillation, activated carbon filtration, and supercritical CO₂ extraction. The companies like Croda and Golden Omega have carved out a niche for themselves in the pharmaceutical-grade purification domain by providing low-toxin ultra-refined fish oils.
Now, the third-party certificates (IFOS, USP, and NSF) have become the key deciders in premium fish oil. Consumers are increasingly conscious of the purity aspect; hence manufacturers are also working on innovative packaging that is oxidation resistant, nitrogen-flushed softgels, and improved-shelf life formulations to uphold product integrity and fulfill the new safety standards.
The fish oil market has been on a steady growth trajectory covering the period 2020 to 2024. This has been mainly attributed to increased awareness of omega-3 benefits among the consumers, newer pharmaceutical applications, and unmet aquaculture demand. To comply with incoming regulations, manufacturers have been working on product development, acquiring sustainability badges, and using sophisticated purification technologies.
Throughout the year, however, uncertainty was caused by supply chain problems, the ups and downs of raw material prices, and the imposition of fishing quotas. In the long term, from 2025 to 2035, demand is expected to grow further due to the wider use of pharmaceutical-grade omega-3s, unique functional formulations, and the discovery of oxidation-resistant fish oils.
Enterprises will diversify into medical nutrition, concentrated high-EPA/DHA, and direct-to-consumer products, while the changes in regulations and environmental concerns will probably also redirect sourcing schemes. The reshaping of the industry dynamics will be facilitated by the competition that the other omega-3 sources, like algae oil, pose, and even the environmental factors.
Fish oil market worldwide is being ruled through two types of companies, which are large companies and specialized companies. The steady concentration level of the market lets the top companies hold a big part of the total market share.
The leading companies in the fish oil market across the globe include and involve some big names such as DSM (Netherlands), BASF SE (Germany), and Croda International Plc (UK). Their diverse variety of products and good international relations with wide-reaching and well-established distribution networks are the keys to their management retained dominance in the market.
Companies like GC Rieber VivoMega (Norway), Pelagia AS (Norway), and FF Skagen A/S (Denmark) follow only in the next line. These companies are mostly the ones who produce fish oil solely, they do this by mostly fishing in certain older areas, and of course, they have a culture of sustainability.Besides, they are famous for being trusted suppliers of responsibly sourced and well-processed fish oil.
The next group includes TASA (Peru), Omega Protein Corporation (USA), Copeinca ASA (Peru), and Golden Omega (Chile). They target very specific market niches such as promoting organic or sustainable fish oil production or they focus on specific end-user industries i.e. dietary supplements and pharmaceuticals. In general, the fish oil world market is moderately concentrated, with the first-rate multinationals gaining an important share of the market.
The mark the second and the third tier of the market, on the other hand, is more dynamic and competitive, with the players utilizing the regional advantages, the specialized product range, or the particular solutions that can meet the wide spectrum of food, and pharmaceuticals that use fish oil as a core ingredient these days.
The following table shows the estimated growth rates of the top three countries. USA, China and Norway are set to exhibit high consumption, and CAGRs of 3.8%, 6.3% and 2.5% respectively, through 2035.
| Countries | CAGR 2025 to 2035 |
|---|---|
| United States | 3.8% |
| China | 6.3% |
| Norway | 2.5% |
China has recently changed a lot in its fish oil industry, starting from the aquaculture model to high-value pharmaceutical applications. The fish oil market in China is being transformed through this process.
China is now becoming one of the top sources of pharmaceutical-grade omega-3 APIs (Active Pharmaceutical Ingredients) in the world as a result of its booming pharmaceutical industry and increasing prescription omega-3 drugs demand. Stand-out local companies like Fuyuan Aquatic, Xiamen Kingdomway, and Zhejiang NBT Marine Biopharmaceutical are heavily focusing on investing in high-purity EPA/DHA for medical applications.
Cardiovascular diseases are becoming a more serious health issue, therefore The National Medical Products Administration of China (NMPA) is intensifying omega-3 API quality regulations, which promote the companies to use more concentrated and refined fish oils.
Furthermore, Chinese businesses are developing capabilities to export high-purity fish oil to the drug manufacturers in Europe and North America. The trend of high-value fish oil products is shifting the psychology of the fish oil industry in China from aquaculture to pharmaceutical roles.
There is an explosion of high-efficiency omega-3 concentrates in the fish oil market in the USA thanks to the specification for personal EPA and DHA formulations that are in demand across clinical nutrition, functional foods, and premium supplements.
The fish oil producers who dominate the territory are like Omega Protein Corporation, DSM Nutritional Products (USA division), and Archer Daniels Midland (ADM), which are reshuffling the cards in the poker game of developing super-concentrated fish oils (≥85% EPA/DHA) powered by fractionation and molecular distillation systems. Consumers tend to search for omega-3 products which are more specific, such as formulas with increased EPA that benefit inflammation and heart health or high DHA that are aimed for brain health.
The bespoke subcriptions to supplement products being more in number and DTC owomega-3 formulations that only focus on potency, purity, and delivery formats are enough reasons this year for establishing this important trend in the USA fish oil market.
Salmon oil is now the market leader in the global fish oil industry with its unmatched omega-3 profile and bioavailability ranking it first in the choice of consumers. Unlike the common fish oils gotten from anchovies or sardines, salmon oil has the nutritiously balanced EPA and DHA that improves absorption, making it a gowild fresher choice among nutraceuticals, pharmaceuticals, and functional foods.
Salmon oils made from cold-pressed and molecularly distilled manufacturing processes by top-producing companies like GC Rieber VivoMega, Epax, and BASF aim to ensure a high level of purity and oxidation stability. Knowing the health benefits they provide, such as the absence of omega-3 the human brain, and the fight against chronic diseases, salmon oil producers are targeting a premium spot in the fish oil segment.
| Segment | Value Share (2025) |
|---|---|
| Salmon Oil (Product Type) | 45% |
The whole industry is moving in the direction of oxidation-resistant fish oils with Norwegian producers being the ones mainly leading the oxidation-resistant fish oil solutions, thus resolving the chronic issue of rancidity and shelf life.
Companies like GC Rieber VivoMega, Pelagia AS, and Epax Norway AS are adapting inventive antioxidant stabilization technologies to keep fish oil fresh and potent for an extended time. Breaking the ground on restart oxygen processing, using natural tocopherols instead of synthetic ones, and nitrogen that is being used to flush out softgel encapsulation now are all the things nearly impossible in the sphere of omega-3 product stability.
These technical developments are obligatory for Norway's leadership in high-end nutraceutical and pharmaceutical-grade fish oils, as they meet the standards of GOED, European Pharmacopeia, and NSF. Furthermore, oxidation control is ameliorating omega-3 in infant nutrition, functional foods, and medical-grade supplements, suming Norway to be a universal power in high-purity, long-lasting fish oil manufacturing.
| Segment | Value Share (2025) |
|---|---|
| Refined Fish Oil (By Process) | 40% |
The fish oil market is currently being led by the market for refined fish oil, which is associated with high purity, greater stability, and the ability to comply with pharmaceutical and nutraceutical standards. Instead of crude fish oil, which contains nanoparticles like heavy metals, dioxins, and other byproducts of oxidation, refined fish oil is distilled so that molecules cannot pass through, is filtered through activated carbon, and is winterized so that there will be more EPA/DHA and no contaminants.
Utilized in the production of ultra-refined fish oils, companies like DSM, Croda International, and Golden Omega are the forefront furious of going for quality salmon omega-3 supplements satisfying GOED, USP, and EP standards.
Refined fish oil is also used in the pharmaceutical industry, functional foods, and in aquaculture feed, which require high purity and stability. As consumers continue to prefer clean-label, high-purity fish oil products the refined segment leads the premium omega-3 market globally.
The fish oil market is a lot of fun, it is a market that is always changing; DSM, BASF, Croda International, GC Rieber VivoMega, and Golden Omega are the key players in the market, thanks to constant innovation, acquisitions, and development of high-purity formulations. To increase market share, manufacturers are improving product purity, launching high-EPA/DHA concentrates, increasing the range of pharmaceutical-grade products with omega-3.
Companies are spending money on functional foods and medical nutrition with microencapsulation and oxidation-resistant technologies. For instance, GC Rieber VivoMega rolled out ultra-refined omega-3 concentrates with better bioavailability, whereas DSM unveiled life’s™ OMEGA as a plant-based alternative to engage flexitarian consumers.
Furthermore, through aquaculture industry partnerships and linking with pharmaceutical firms, they are enhacing revenue streams. Market leaders are now more interested in high-potency, purity-certified fish oils to hold their competitive advantage mainly as a result of consumers opting for personalized omega-3 products.
Within the Forecast Period, the market is expected to grow at a CAGR of 9%.
By 2035, the sales value of the industry is expected to reach USD 24,624.1 million.
Feed Grade, Food Grade, Pharma Grade
Salmon Oil, Tuna Oil, Cod Liver Oil, Sardine Oil, Squalene Oil, Krill Oil, Anchovy Oil, Menhaden Oil and Others
Crude Fish Oil, Refined Fish Oil, Modified Fish Oil
Aqua-Feed, Food and Beverages, Dietary Supplements, Cosmetic and Beauty Products
Industry analysis has been carried out in key countries of North America, Latin America, Europe, Middle East and Africa, East Asia, South Asia, and Oceania
Dairy Flavors Market Trends – Growth & Industry Forecast 2025 to 2035
Egg Protein Market Insights – High-Protein Nutrition & Market Growth 2025 to 2035
Dried Eggs Market Insights – Shelf-Stable Nutrition & Industry Growth 2025 to 2035
Egg Substitute Market Insights – Plant-Based Alternatives & Industry Growth 2025 to 2035
Egg-Free Dressing Market Trends – Growth & Innovation 2025 to 2035
Dried Spent Grain Market Trends – Growth & Industry Forecast 2025 to 2035
Fish Oil Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
